MADAM THERAPEUTICS
Madam Therapeutics is a biotech startup, developing sustainable, pragmatic solutions to alleviate the burden of infectious diseases. The company has a portfolio of various antimicrobial peptides that it is developing into a firm product pipeline. Madam Therapeutics is currently developing products to treat and prevent bacterial infections for nasal MRSA carriers, in burn wounds, for atopic dermatitis, as well as for coatings of biomaterials. It was founded in 2011 and is headquartered in Amsterdam, Netherlands.
MADAM THERAPEUTICS
Industry:
Biotechnology Medical
Founded:
2011-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.madam-therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+31202170002
Total Funding:
1.35 M EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Akismet Akismet Non Hosted Hostnet Netherlands
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Remko van Leeuwen CEO @ Madam Therapeutics
CEO
2011-04-01
Michel de Baar CBO @ Madam Therapeutics
CBO
Founder
Investors List
Investormatch
Investormatch investment in Venture Round - Madam Therapeutics
Ekoy Investment Partners
Ekoy Investment Partners investment in Venture Round - Madam Therapeutics
De Investeerders Club
De Investeerders Club investment in Venture Round - Madam Therapeutics
Dutch Technology Foundation STW
Dutch Technology Foundation STW investment in Grant - Madam Therapeutics
Official Site Inspections
http://www.madam-therapeutics.com
- Host name: balancing.hostnet.nl
- IP address: 91.184.0.200
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Madam Therapeutics"
Madam Therapeutics - Crunchbase Company Profile & Funding
Madam Therapeutics is currently developing products to treat and prevent bacterial infections for nasal MRSA carriers, in burn wounds, for atopic dermatitis, as well as for coatings of …See details»
Madam Therapeutics - LinkedIn
Madam Therapeutics develops next-generation antibiotics for the treatment of multi-drug resistant (MDR) infectious diseases • The company has developed a breakthrough platform technology of...See details»
Madam Therapeutics BV - Drug pipelines, Patents, Clinical trials
Explore Madam Therapeutics BV with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Infectious Diseases, Technology Platform:Synthetic peptide, …See details»
Madam Therapeutics - Org Chart, Teams, Culture
View Madam Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Madam Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Madam Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Madam Therapeutics BV - Company Profile and News
Madam Therapeutics B.V. operates as a biotechnology company. The Company develops synthetic anti-microbial and anti-biofilm peptides to combat resistant bacterial infections. …See details»
Madam Therapeutics - Contacts, Employees, Board Members
Madam Therapeutics is a biotech startup, developing sustainable, pragmatic solutions to alleviate the burden of infectious diseases.See details»
Madam Therapeutics - Funding, Financials, Valuation & Investors
Madam Therapeutics is a biotech startup, developing sustainable, pragmatic solutions to alleviate the burden of infectious diseases.See details»
Madam Therapeutics Company Profile - Office Locations ... - Craft
Madam Therapeutics is a biotech company developing antibiotics. It offers synthetic anti-microbial and anti-biofilm peptides (SAAPs) to combat resistant bacterial infections. Additionally, the …See details»
Madam Therapeutics - Products, Competitors, Financials, …
Madam Therapeutics is a biotechnology company focused on developing next-generation antibiotics to combat multi-drug resistant infectious diseases. Use the CB Insights Platform to …See details»
AiCuris nominates Madam Therapeutics with its innovative peptide ...
Apr 8, 2022 · Madam Therapeutics generated pre-clinical proof-of-concept (POC) data in superficial wound infections, implant infections, as well as pulmonary and bladder infections, …See details»
Madam Therapeutics - VentureRadar
Website: http://www.madam-therapeutics.com Develops novel antibiotics, specifically Synthetic Anti-Microbial and Anti-Biofilm Peptides (SAAPs), to combat resistant bacterial infections in …See details»
Madam Therapeutics | VentureRadar
Madam is an acronym for Molecular Anti-infective Drugs from Amsterdam. The company is currently developing products to treat and/or prevent bacterial infections for nasal MRSA …See details»
Madam Therapeutics - Crunchbase
Madam Therapeutics is a biotech startup, developing sustainable, pragmatic solutions to alleviate the burden of infectious diseases.See details»
Madam Therapeutics closes first financing round to develop novel …
Aug 28, 2018 · Madam Therapeutics, a privately-held biotech company that is developing a novel class of antibiotics inspired by the defense mechanisms of the human body, today announced …See details»
Madam Therapeutics has been awarded a grant from the …
Oct 30, 2018 · Madam Therapeutics announced that it is one of the four companies in the Netherlands that have been awarded a novel grant from the Netherlands Antibiotic …See details»
Madam Therapeutics closes first financing round to develop novel ...
Aug 27, 2018 · Madam Therapeutics closed its first financing round of 1,1M EUR. The biotech company develops a novel class of antibiotics inspired by the defense mechanisms of the …See details»
Madam Therapeutics - Tech Stack, Apps, Patents & Trademarks
Madam Therapeutics is a biotech startup, developing sustainable, pragmatic solutions to alleviate the burden of infectious diseases.See details»
SAAP 148 - AdisInsight - Springer
Feb 28, 2023 · SAAP 148, a Synthetic Antimicrobial Antibiofilm Peptide (SAAP), is being developed by Madam Therapeutics (spin-off of Leiden University), for the treatment ofSee details»
Madam Therapeutics - VentureRadar
Madam is an acronym for Molecular Anti-infective Drugs from Amsterdam. The company is currently developing products to treat and/or prevent bacterial infections for nasal MRSA …See details»